Depressive Disorders - Saudi Arabia

Revenue in the Depressive Disorders market is projected to reach US$101.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.22%, resulting in a market volume of US$102.70m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$47.20 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Saudi Arabia is experiencing significant growth and development due to several factors.

Customer preferences: In recent years, there has been a growing awareness and understanding of mental health issues in Saudi Arabia. This has led to an increased demand for diagnosis and treatment of depressive disorders. Customers are seeking effective and accessible solutions to manage their mental health, leading to a rise in the demand for medications and therapies specifically targeted towards depressive disorders.

Trends in the market: One of the key trends in the Depressive Disorders market in Saudi Arabia is the shift towards personalized medicine. Healthcare providers are increasingly focusing on tailoring treatment plans to individual patients, taking into account their specific symptoms, medical history, and genetic factors. This trend is driving the development of innovative therapies and medications that can provide more targeted and effective treatment for depressive disorders.Another trend in the market is the growing adoption of telemedicine and digital health solutions. With the increasing use of smartphones and internet connectivity, patients are now able to access mental health services remotely, without the need for in-person visits to healthcare facilities. This has not only increased the accessibility of mental health services, but also improved the overall patient experience.

Local special circumstances: Saudi Arabia has a young population, with a large percentage of the population under the age of 30. This demographic is more open to discussing mental health issues and seeking treatment compared to previous generations. Additionally, the government has been actively promoting mental health awareness and providing support for individuals with mental health disorders. These factors have contributed to the growing acceptance and demand for mental health services, including those for depressive disorders.

Underlying macroeconomic factors: The Saudi Arabian economy has been diversifying away from its traditional reliance on oil, with a focus on developing sectors such as healthcare. The government has made significant investments in healthcare infrastructure and services, including mental health. This has resulted in improved access to mental health services, increased availability of medications, and the development of specialized mental health centers.Furthermore, the COVID-19 pandemic has had a significant impact on the Depressive Disorders market in Saudi Arabia. The pandemic has led to increased stress, anxiety, and depression among the population, resulting in a higher demand for mental health services. The government has recognized the importance of addressing mental health during these challenging times and has taken steps to provide support and resources for individuals struggling with depressive disorders.In conclusion, the Depressive Disorders market in Saudi Arabia is experiencing growth and development due to increasing customer preferences for personalized medicine and digital health solutions, as well as local special circumstances such as a young and more open population. The underlying macroeconomic factors, including government investments in healthcare and the impact of the COVID-19 pandemic, have also contributed to the growth of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.